The population dynamics of the human microbiome have been associated with inflammatory
bowel disease, cancer, obesity, autoimmune diseases, and many other human disease …

The specificity of biological systems makes it possible to develop biosensors targeting
specific metabolites, toxins, and pollutants in complex medical or environmental samples …

The probiotic yeast Saccharomyces boulardii (Sb) is a promising chassis to deliver
therapeutic proteins to the gut due to Sb's innate therapeutic properties, resistance to phage …

Saccharomyces boulardii (Sb) is an emerging probiotic chassis for delivering biomolecules
to the mammalian gut, offering unique advantages as the only eukaryotic probiotic …

Biosensors are valuable tools in accelerating the test phase of the design‐build‐test‐learn
cycle of cell factory development, as well as in bioprocess monitoring and control. G protein …

Drug-target interaction databases comprise millions of manually curated data points, yet
there are missed opportunities for repurposing established interaction networks to infer …

Chimeric antigen receptor (CAR) T cells have become an established form of
immunotherapy and continue to show promising results for the treatment of hematological …

The production of bio-based chemicals and fuels through microbial engineering offers a
promising and sustainable alternative to petroleum-based fuels and chemicals, with the …

Chimeric antigen receptor (CAR) T cells have become an established immunotherapy and
show promising results for the treatment of hematological cancers in most patients …

Engineered probiotics are genetically modified microorganisms to perform sophisticated
diagnostic, preventative and/or therapeutic functions in the gut. Up to date, majority of this …